Open AccessSymptomatic arterial hypertension associated with primary hyperaldosteronism
Author(s) -
А. Н. Калягин,
В. А. Белобородов,
Tatyana Maksikova
Publication year - 2017
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2017-23-3-224-230
Subject(s) - hyperaldosteronism , medicine , rhabdomyolysis , aldosterone , secondary hypertension , creatine kinase , lactate dehydrogenase , cardiology , blood pressure , enzyme , biochemistry , chemistry
Objective. Primary hyperaldosteronism (PGA) (Conn’s syndrome) is a relatively rare phenomenon in therapeutic practice, occurring in 4,7–9%. In resistant hypertension (HTN) the rate of PGA achieves 10–20%. Often it results from the aldosterone-producing adrenal tumors and manifests by symptomatic HTN, neuromuscular, and renal symptoms. We present the cases of successful verification and surgical treatment of PGA. HTN patients and patients with rhabdomyolysis symptoms (increased creatine phosphokinase or lactate dehydrogenase) require further examination to exclude PGA.